These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21069389)

  • 21. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of residual renal function using beta-trace protein: Impact of dialysis procedures.
    Bargnoux AS; Buthiau D; Morena M; Rodriguez A; Noguera-Gonzalez ME; Gilbert O; Le Quintrec M; Kuster N; Cristol JP
    Artif Organs; 2020 Jun; 44(6):647-654. PubMed ID: 31951029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solute Clearance and Fluid Removal: Large-Dose Cyclic Tidal Peritoneal Dialysis.
    Hibino S; Uemura O; Uchida H; Majima H; Yamaguchi R; Tanaka K; Kawaguchi A; Yamakawa S; Fujita N
    Ther Apher Dial; 2019 Apr; 23(2):180-186. PubMed ID: 30259676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between residual renal function and peritoneal clearance for Na/H2O and urea removal in peritoneal dialysis patients.
    Shan Y; Xu F; Sun M; Ji J; Ding X
    Ren Fail; 2014 Aug; 36(7):1008-12. PubMed ID: 24896304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C as marker of residual renal function in patients on peritoneal dialysis: relation with parameters of peritoneal function.
    Ros S; Bajo A; del Peso G; Garcia de Miguel A; Santacruz S; Fernandez E; de Garcia R; Selgas R
    J Nephrol; 2007; 20(4):468-73. PubMed ID: 17879214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between Kt/V(urea) and nPNA in anuric peritoneal dialysis patients: a comparison with predialysis patients.
    Jansen MA; Korevaar JC; Dekker FW; Jager KJ; Boeschoten EW; Krediet RT;
    Perit Dial Int; 2001; 21(5):509-15. PubMed ID: 11757836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creatinine clearance in continuous peritoneal dialysis: dialysis dose required for a minimal acceptable level.
    Tzamaloukas AH; Murata GH; Malhotra D; Fox L; Goldman RS; Avasthi PS
    Perit Dial Int; 1996; 16(1):41-7. PubMed ID: 8616171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis.
    Huang SH; Filler G; Yasin A; Lindsay RM
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):319-25. PubMed ID: 21115625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function.
    Rocco MV; Frankenfield DL; Prowant B; Frederick P; Flanigan MJ;
    Perit Dial Int; 2002; 22(3):371-9. PubMed ID: 12227396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual renal function calculated from serum cystatin C measurements and knowledge of the weekly standard Kt/V urea.
    Huang SH; Filler G; Lindsay RM
    Perit Dial Int; 2012; 32(1):102-4. PubMed ID: 22302925
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial.
    Rutkowski B; Tam P; van der Sande FM; Vychytil A; Schwenger V; Himmele R; Gauly A;
    Am J Kidney Dis; 2016 May; 67(5):753-61. PubMed ID: 26388284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of cystatin C-based equations for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis.
    Zhong H; Zhang W; Qin M; Gou Z; Feng P
    Nephrol Dial Transplant; 2017 Jun; 32(6):1032-1040. PubMed ID: 27190348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that urea is a better surrogate marker of uremic toxicity than creatinine.
    Mehrotra R; Saran R; Nolph KD; Moore HL; Khanna R
    ASAIO J; 1997; 43(5):M858-61. PubMed ID: 9360168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selected outcome criteria and adequacy of dialysis in diabetic and elderly patients on CAPD therapy.
    Mooraki A; Kliger AS; Juergensen P; Gorban-Brennan N; Finkelstein FO
    Adv Perit Dial; 1994; 10():89-93. PubMed ID: 7999872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of renal Kt/V as a marker of renal function in predialysis patients.
    Kuhlmann MK; Heckmann M; Riegel W; Köhler H
    Kidney Int; 2001 Oct; 60(4):1540-6. PubMed ID: 11576370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients.
    Hur SM; Ju HY; Park MY; Choi SJ; Kim JK; Hwang SD
    Korean J Intern Med; 2014 Jul; 29(4):489-97. PubMed ID: 25045297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of cystatin C-derived equations for evaluation of residual renal function in peritoneal dialysis patients.
    Ahmadi F; Rahmani F; Lessan-Pezeshki M; Azmandian J
    Ren Fail; 2015 Feb; 37(1):50-6. PubMed ID: 25268834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weekly clearances of urea and creatinine on CAPD and NIPD.
    Nolph KD; Twardowski ZJ; Keshaviah PR
    Perit Dial Int; 1992; 12(3):298-303. PubMed ID: 1511047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.